Selected research
Industry Research
Cold and Flu Supplement Industry Research Report 2026
Market perspective
The global Cold and Flu Supplement market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cold and Flu Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cold and Flu Supplement market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cold and Flu Supplement market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cold and Flu Supplement include Pfizer, GlaxoSmithKline, Wakunaga of America, The Vitamin Shoppe, NOW Foods, Nordic Naturals, Neurobiologix, Klaire Labs and Himalaya Global Holdings, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cold and Flu Supplement market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cold and Flu Supplement.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cold and Flu Supplement Market by Company
Pfizer
GlaxoSmithKline
Wakunaga of America
The Vitamin Shoppe
NOW Foods
Nordic Naturals
Neurobiologix
Klaire Labs
Himalaya Global Holdings
Flora
FineVine
Dr. Willmar Schwabe GmbH
Cold and Flu Supplement Segment by Type
Herbal Extracts
Natural Molecules
Vitamins and Minerals
Others
Cold and Flu Supplement Segment by Application
Online
Offline
Cold and Flu Supplement Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cold and Flu Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cold and Flu Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cold and Flu Supplement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cold and Flu Supplement companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Herbal Extracts
- Natural Molecules
- Vitamins and Minerals
- Others
Applications
- Online
- Offline
Companies covered
- Pfizer
- GlaxoSmithKline
- Wakunaga of America
- The Vitamin Shoppe
- NOW Foods
- Nordic Naturals
- Neurobiologix
- Klaire Labs
- Himalaya Global Holdings
- Flora
- FineVine
- Dr. Willmar Schwabe GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cold and Flu Supplement by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Herbal Extracts
- 2.2.3 Natural Molecules
- 2.2.4 Vitamins and Minerals
- 2.2.5 Others
- 2.3 Cold and Flu Supplement by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Online
- 2.3.3 Offline
- 2.4 Assumptions and Limitations
3 Cold and Flu Supplement Breakdown Data by Type
- 3.1 Global Cold and Flu Supplement Historic Market Size by Type (2021-2026)
- 3.2 Global Cold and Flu Supplement Forecasted Market Size by Type (2027-2032)
4 Cold and Flu Supplement Breakdown Data by Application
- 4.1 Global Cold and Flu Supplement Historic Market Size by Application (2021-2026)
- 4.2 Global Cold and Flu Supplement Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cold and Flu Supplement Market Perspective (2021-2032)
- 5.2 Global Cold and Flu Supplement Growth Trends by Region
- 5.2.1 Global Cold and Flu Supplement Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cold and Flu Supplement Historic Market Size by Region (2021-2026)
- 5.2.3 Cold and Flu Supplement Forecasted Market Size by Region (2027-2032)
- 5.3 Cold and Flu Supplement Market Dynamics
- 5.3.1 Cold and Flu Supplement Industry Trends
- 5.3.2 Cold and Flu Supplement Market Drivers
- 5.3.3 Cold and Flu Supplement Market Challenges
- 5.3.4 Cold and Flu Supplement Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cold and Flu Supplement Players by Revenue
- 6.1.1 Global Top Cold and Flu Supplement Players by Revenue (2021-2026)
- 6.1.2 Global Cold and Flu Supplement Revenue Market Share by Players (2021-2026)
- 6.2 Global Cold and Flu Supplement Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cold and Flu Supplement Head Office and Area Served
- 6.4 Global Cold and Flu Supplement Players, Product Type & Application
- 6.5 Global Cold and Flu Supplement Manufacturers Established Date
- 6.6 Global Cold and Flu Supplement Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cold and Flu Supplement Market Size (2021-2032)
- 7.2 North America Cold and Flu Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cold and Flu Supplement Market Size by Country (2021-2026)
- 7.4 North America Cold and Flu Supplement Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cold and Flu Supplement Market Size (2021-2032)
- 8.2 Europe Cold and Flu Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cold and Flu Supplement Market Size by Country (2021-2026)
- 8.4 Europe Cold and Flu Supplement Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cold and Flu Supplement Market Size (2021-2032)
- 9.2 Asia-Pacific Cold and Flu Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cold and Flu Supplement Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cold and Flu Supplement Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cold and Flu Supplement Market Size (2021-2032)
- 10.2 South America Cold and Flu Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cold and Flu Supplement Market Size by Country (2021-2026)
- 10.4 South America Cold and Flu Supplement Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cold and Flu Supplement Market Size (2021-2032)
- 11.2 Middle East & Africa Cold and Flu Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cold and Flu Supplement Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cold and Flu Supplement Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Pfizer
- 12.1.1 Pfizer Company Information
- 12.1.2 Pfizer Business Overview
- 12.1.3 Pfizer Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.1.4 Pfizer Cold and Flu Supplement Product Portfolio
- 12.1.5 Pfizer Recent Developments
- 12.2 GlaxoSmithKline
- 12.2.1 GlaxoSmithKline Company Information
- 12.2.2 GlaxoSmithKline Business Overview
- 12.2.3 GlaxoSmithKline Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.2.4 GlaxoSmithKline Cold and Flu Supplement Product Portfolio
- 12.2.5 GlaxoSmithKline Recent Developments
- 12.3 Wakunaga of America
- 12.3.1 Wakunaga of America Company Information
- 12.3.2 Wakunaga of America Business Overview
- 12.3.3 Wakunaga of America Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.3.4 Wakunaga of America Cold and Flu Supplement Product Portfolio
- 12.3.5 Wakunaga of America Recent Developments
- 12.4 The Vitamin Shoppe
- 12.4.1 The Vitamin Shoppe Company Information
- 12.4.2 The Vitamin Shoppe Business Overview
- 12.4.3 The Vitamin Shoppe Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.4.4 The Vitamin Shoppe Cold and Flu Supplement Product Portfolio
- 12.4.5 The Vitamin Shoppe Recent Developments
- 12.5 NOW Foods
- 12.5.1 NOW Foods Company Information
- 12.5.2 NOW Foods Business Overview
- 12.5.3 NOW Foods Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.5.4 NOW Foods Cold and Flu Supplement Product Portfolio
- 12.5.5 NOW Foods Recent Developments
- 12.6 Nordic Naturals
- 12.6.1 Nordic Naturals Company Information
- 12.6.2 Nordic Naturals Business Overview
- 12.6.3 Nordic Naturals Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.6.4 Nordic Naturals Cold and Flu Supplement Product Portfolio
- 12.6.5 Nordic Naturals Recent Developments
- 12.7 Neurobiologix
- 12.7.1 Neurobiologix Company Information
- 12.7.2 Neurobiologix Business Overview
- 12.7.3 Neurobiologix Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.7.4 Neurobiologix Cold and Flu Supplement Product Portfolio
- 12.7.5 Neurobiologix Recent Developments
- 12.8 Klaire Labs
- 12.8.1 Klaire Labs Company Information
- 12.8.2 Klaire Labs Business Overview
- 12.8.3 Klaire Labs Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.8.4 Klaire Labs Cold and Flu Supplement Product Portfolio
- 12.8.5 Klaire Labs Recent Developments
- 12.9 Himalaya Global Holdings
- 12.9.1 Himalaya Global Holdings Company Information
- 12.9.2 Himalaya Global Holdings Business Overview
- 12.9.3 Himalaya Global Holdings Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.9.4 Himalaya Global Holdings Cold and Flu Supplement Product Portfolio
- 12.9.5 Himalaya Global Holdings Recent Developments
- 12.10 Flora
- 12.10.1 Flora Company Information
- 12.10.2 Flora Business Overview
- 12.10.3 Flora Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.10.4 Flora Cold and Flu Supplement Product Portfolio
- 12.10.5 Flora Recent Developments
- 12.11 FineVine
- 12.11.1 FineVine Company Information
- 12.11.2 FineVine Business Overview
- 12.11.3 FineVine Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.11.4 FineVine Cold and Flu Supplement Product Portfolio
- 12.11.5 FineVine Recent Developments
- 12.12 Dr. Willmar Schwabe GmbH
- 12.12.1 Dr. Willmar Schwabe GmbH Company Information
- 12.12.2 Dr. Willmar Schwabe GmbH Business Overview
- 12.12.3 Dr. Willmar Schwabe GmbH Revenue in Cold and Flu Supplement Business (2021-2026)
- 12.12.4 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Product Portfolio
- 12.12.5 Dr. Willmar Schwabe GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst